Long-Term Anticoagulation in Secondary Ischemic Stroke Prevention: The Prospective Multicenter RESTAIC Registry

Background and Objective: Oral anticoagulation (OAC) for secondary stroke prevention is recommended in atrial fibrillation (AF) and other sources of cardioembolic stroke. Our objectives were to explore the differences in ischemic and hemorrhagic events when using OAC for secondary stroke prevention...

Descripción completa

Detalles Bibliográficos
Autores principales: Gutiérrez-Zúñiga, Raquel, Rigual, Ricardo, Torres-Iglesias, Gabriel, Sánchez-Velasco, Sara, Alonso de Leciñana, María, Masjuan, Jaime, Álvarez Velasco, Rodrigo, Navas, Inmaculada, Izquierdo-Esteban, Laura, Fernández-Ferro, José, Rodríguez-Pardo, Jorge, Ruiz-Ares, Gerardo, Zapata-Wainberg, Gustavo, Fuentes, Blanca, Díez-Tejedor, Exuperio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7641639/
https://www.ncbi.nlm.nih.gov/pubmed/33193025
http://dx.doi.org/10.3389/fneur.2020.575634

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7641639/
https://www.ncbi.nlm.nih.gov/pubmed/33193025
http://dx.doi.org/10.3389/fneur.2020.575634

Ejemplares similares